Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:789-790 (8 October), doi:10.1136/bmj.331.7520.789
2 mm plus radiotherapy is as good as a bigger margin
| The first 150 words of the full text of this article appear below. |
The widespread use of mammography screening has led to a change in the perceived pathology of breast cancer. The increased detection of asymptomatic disease has resulted in an increased incidence of ductal carcinoma in situ (DCIS), which now accounts for about 20% of all cases of breast cancer. In addition, the past decade has seen a change in the management of primary breast cancer, from mastectomy to breast conservation where possible.1 Clearly surgical management of DCIS poses several challenges, none more so than what should be the width of an adequate margin of resection. What is at issue is the size of the margin that ensures no residual tumour cells while minimising the deformity of the breast.
The National Surgical Adjuvant Breast and Bowel Project (NSABP) regards "no tumour cells on the ink"that is, a minimal margin free of diseaseas a negative margin. Yet in a recent survey of
Malcolm R Kell, fellow in surgical oncology
(malcolmkell@eircom.net)
Department of Surgery, Fox Chase Cancer Centre, Philadelphia, PA 19111, USA
Monica Morrow, chairman, department of surgical oncology
Department of Surgery, Fox Chase Cancer Centre, Philadelphia, PA 19111, USA
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.